BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33103214)

  • 1. ASO Author Reflections: The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality.
    Poulson MR; Blanco BA; Sachs TE
    Ann Surg Oncol; 2021 Jun; 28(6):3156. PubMed ID: 33103214
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: It is Time to Prioritize Exercise in Pancreatic Cancer Survivorship.
    Parker NH; Katz MHG
    Ann Surg Oncol; 2021 Apr; 28(4):2310-2311. PubMed ID: 32886285
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Low Genetic Testing Utilization Among Patients with Breast, Ovarian, Pancreatic, and Prostate Cancers.
    Clark NM; Flanagan MR
    Ann Surg Oncol; 2023 Mar; 30(3):1327-1328. PubMed ID: 36322272
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
    Tsilimigras DI; Moris D; Pawlik TM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):610-611. PubMed ID: 31087182
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Understanding the Broader Implications of the Volume-Outcome Impact on Pancreas Cancer Surgery.
    Acher AW; Weber SM; Pawlik TM
    Ann Surg Oncol; 2022 Feb; 29(2):1269-1270. PubMed ID: 34537896
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery.
    Tummers WS; Rosenthal EL; Vahrmeijer AL; Poultsides GA
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):820-821. PubMed ID: 30315384
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Prediction of the Chemotherapy Effect on the Prognosis of Locally Advanced Pancreatic Cancer.
    Tanaka M; Hackert T
    Ann Surg Oncol; 2023 Apr; 30(4):2409-2410. PubMed ID: 36209330
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Long-Term Impact of Pancreatoduodenectomy on Pancreas-Specific Quality of Life.
    Fong ZV; Ferrone CR
    Ann Surg Oncol; 2021 Aug; 28(8):4225-4226. PubMed ID: 33759048
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Neighborhood Disadvantage and Pancreas Cancer Surgical Outcomes.
    Marcinak CT; Zafar SN
    Ann Surg Oncol; 2024 Jan; 31(1):550-551. PubMed ID: 37851199
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: How Does Cholestasis Worsen Pancreatic Cancer Progression?
    Sarkar J; Takabe K
    Ann Surg Oncol; 2023 Mar; 30(3):1642-1643. PubMed ID: 36529779
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Gastroduodenal Artery Involvement is a Prognostic Factor in Patients with Pancreatic Head Cancer.
    Kado T; Tomimaru Y; Kobayashi S; Takahashi H; Sasaki K; Iwagami Y; Yamada D; Noda T; Doki Y; Eguchi H
    Ann Surg Oncol; 2023 Apr; 30(4):2422. PubMed ID: 36383332
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Chemoradiation as the Mainstay of Therapy for Nonagenarians with Pancreatic Cancer.
    Meltzer RS; Maithel SK; Shah MM
    Ann Surg Oncol; 2021 Apr; 28(4):2273-2274. PubMed ID: 33386545
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Improving Outcomes and Minimizing Variability in Pancreatic Cancer Care: A Study of Ontario and the United States.
    Saadat LV; Wei AC
    Ann Surg Oncol; 2024 Mar; 31(3):1937-1938. PubMed ID: 37865939
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Racial Disparities in Chemoresponsivity in Localized Pancreatic Cancer: Nature or Nurture?
    Hester CA; Ogobuiro IC; Merchant NB; Datta J
    Ann Surg Oncol; 2023 Mar; 30(3):1495-1497. PubMed ID: 36402894
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All?
    da Costa WL; Massarweh NN
    Ann Surg Oncol; 2021 Jun; 28(6):3196-3197. PubMed ID: 33221979
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms.
    Al Efishat M; Allen PJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):822-823. PubMed ID: 30324467
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Preoperative Nutritional Care: The 'Cinderella' of Surgical Management in Patients with Pancreatic Cancer.
    Paiella S; Trestini I; Milella M; Salvia R
    Ann Surg Oncol; 2020 Dec; 27(13):5335-5336. PubMed ID: 32356267
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Addressing Racial Disparities in Pancreatic Cancer: How Can We Do Better?
    Anteby R; Qadan M
    Ann Surg Oncol; 2023 Apr; 30(4):2482-2483. PubMed ID: 36652023
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Real Prevalence of Occult Cancer Cells in Peritoneal Lavage in Patients with Pancreatic Ductal Adenocarcinoma.
    Suenaga M; Fujii T
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):893-894. PubMed ID: 32812111
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration.
    Del Valle JP; Gold JS
    Ann Surg Oncol; 2022 May; 29(5):3203-3204. PubMed ID: 35015185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.